SILO PHARMA, INC. Professional Fees
SILO PHARMA, INC. (SILO) reported Professional Fees of $311.85 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2026-08-13
- SILO PHARMA, INC. professional fees for the quarter ending 2026-06-30 was $311.85K, a 4.09% increase year-over-year.
- SILO PHARMA, INC. professional fees for the quarter ending 2026-03-31 was $255.29K, a 6.77% decline year-over-year.
- SILO PHARMA, INC. professional fees for the quarter ending 2025-12-31 was $172.00K, a 42.44% decline year-over-year.
- SILO PHARMA, INC. professional fees for the quarter ending 2025-09-30 was $313.19K, a 20.98% increase year-over-year.
- SILO PHARMA, INC. professional fees for fiscal 2023 was $1.73M, a 15.33% increase from fiscal 2022.
- SILO PHARMA, INC. professional fees for fiscal 2022 was $1.50M, a 6.36% decline from fiscal 2021.
- SILO PHARMA, INC. professional fees for fiscal 2021 was $1.60M, a 36.18% increase from fiscal 2020.
- SILO PHARMA, INC. professional fees for fiscal 2020 was $1.17M, a 172.31% increase from fiscal 2019.
| Period end | Professional Fees | Professional Fees 3 month | Professional Fees 3 month as first filed | Professional Fees 6 month | Professional Fees 6 month as first filed | Professional Fees 9 month | Professional Fees 9 month as first filed | Professional Fees 12 month | Professional Fees 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $311.85K 10-Q · filed 2026-08-13 | $567.14K 10-Q · filed 2026-08-13 | $739.14K derived: sum of 3 quarters · filed 2026-08-13 | $1.05M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2026-03-31 | $255.29K 10-Q · filed 2026-05-14 | $427.29K derived: sum of 2 quarters · filed 2026-05-14 | $740.49K derived: sum of 3 quarters · filed 2026-05-14 | $1.04M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2026-02-20 | $250.00K 10-Q · filed 2026-08-13 | ||||||||
| 2025-12-31 | $172.00K derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-14 | $485.19K derived: sum of 2 quarters · filed 2026-04-14 | $784.78K derived: sum of 3 quarters · filed 2026-08-13 | $1.06M POS AM · filed 2026-04-14 | |||||
| 2025-09-30 | $313.19K 10-Q · filed 2025-11-13 | $612.79K derived: sum of 2 quarters · filed 2026-08-13 | $886.61K 10-Q · filed 2025-11-13 | $1.19M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-06-30 | $299.59K 10-Q · filed 2026-08-13 | $573.42K 10-Q · filed 2026-08-13 | $872.21K derived: sum of 3 quarters · filed 2026-08-13 | $1.13M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-03-31 | $273.82K 10-Q · filed 2026-05-14 | $572.62K derived: sum of 2 quarters · filed 2026-05-14 | $831.50K derived: sum of 3 quarters · filed 2026-05-14 | $1.22M derived: sum of 4 quarters · filed 2026-05-14 | |||||
| 2024-12-31 | $298.79K derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-14 | $557.68K derived: sum of 2 quarters · filed 2026-04-14 | $944.14K derived: sum of 3 quarters · filed 2026-04-14 | $1.20M POS AM · filed 2026-04-14 | |||||
| 2024-09-30 | $258.89K 10-Q · filed 2025-11-13 | $645.35K derived: sum of 2 quarters · filed 2025-11-13 | $899.95K 10-Q · filed 2025-11-13 | $1.42M derived: sum of 4 quarters · filed 2025-11-13 | |||||
| 2024-06-30 | $386.46K 10-Q · filed 2025-08-13 | $641.07K 10-Q · filed 2025-08-13 | $1.16M derived: sum of 3 quarters · filed 2025-08-13 | $1.50M derived: sum of 4 quarters · filed 2025-08-13 | |||||
| 2024-03-31 | $318.43K 10-Q · filed 2025-05-09 | $770.76K derived: sum of 2 quarters · filed 2025-05-09 | $1.11M derived: sum of 3 quarters · filed 2025-05-09 | $1.68M derived: sum of 4 quarters · filed 2025-05-09 | |||||
| 2023-12-31 | $452.33K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $790.50K derived: sum of 2 quarters · filed 2025-03-28 | $1.36M derived: sum of 3 quarters · filed 2025-03-28 | $1.73M 10-K · filed 2025-03-28 | |||||
| 2023-09-30 | $338.16K 10-Q · filed 2024-11-12 | $908.46K derived: sum of 2 quarters · filed 2024-11-12 | $1.27M 10-Q · filed 2024-11-12 | $1.92M derived: sum of 4 quarters · filed 2024-11-12 | |||||
| 2023-06-30 | $570.29K 10-Q · filed 2024-08-13 | $935.57K 10-Q · filed 2024-08-13 | $1.59M derived: sum of 3 quarters · filed 2024-08-13 | $1.99M derived: sum of 4 quarters · filed 2024-08-13 | |||||
| 2023-03-31 | $365.27K 10-Q · filed 2024-05-13 | $1.02M derived: sum of 2 quarters · filed 2024-05-13 | $1.42M derived: sum of 3 quarters · filed 2024-05-13 | $1.67M derived: sum of 4 quarters · filed 2024-05-13 | |||||
| 2022-12-31 | $650.07K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $1.05M derived: sum of 2 quarters · filed 2024-03-25 | $1.30M derived: sum of 3 quarters · filed 2024-03-25 | $1.50M 10-K · filed 2024-03-25 | |||||
| 2022-09-30 | $402.19K 10-Q · filed 2023-11-13 | $650.37K derived: sum of 2 quarters · filed 2023-11-13 | $846.62K 10-Q · filed 2023-11-13 | $1.17M derived: sum of 4 quarters · filed 2023-11-13 | |||||
| 2022-06-30 | $248.18K 10-Q · filed 2023-08-11 | $444.43K 10-Q · filed 2023-08-11 | $768.90K derived: sum of 3 quarters · filed 2023-08-11 | $1.10M derived: sum of 4 quarters · filed 2023-08-11 | |||||
| 2022-03-31 | $196.25K 10-Q · filed 2023-05-12 | $520.72K derived: sum of 2 quarters · filed 2023-05-12 | $852.14K derived: sum of 3 quarters · filed 2023-05-12 | $1.12M derived: sum of 4 quarters · filed 2023-05-12 | |||||
| 2021-12-31 | $324.47K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $655.89K derived: sum of 2 quarters · filed 2023-03-24 | $926.80K derived: sum of 3 quarters · filed 2023-03-24 | $1.60M 10-K · filed 2023-03-24 | |||||
| 2021-09-30 | $331.42K 10-Q · filed 2022-11-10 | $602.33K derived: sum of 2 quarters · filed 2022-11-10 | $1.27M 10-Q · filed 2022-11-10 | $1.69M derived: sum of 4 quarters · filed 2022-11-10 | |||||
| 2021-06-30 | $270.91K 10-Q · filed 2022-08-01 | $299.80K 10-Q · filed 2021-08-13 | $942.48K 10-Q · filed 2022-08-01 | $998.51K 10-Q · filed 2021-08-13 | $1.36M derived: sum of 3 quarters · filed 2022-08-01 | $1.77M derived: sum of 4 quarters · filed 2022-08-01 | |||
| 2021-03-31 | $671.57K 10-Q · filed 2022-05-13 | $698.71K 10-Q · filed 2021-05-17 | $1.09M derived: sum of 2 quarters · filed 2022-05-13 | $1.50M derived: sum of 3 quarters · filed 2022-05-13 | $1.82M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $416.10K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $831.51K derived: sum of 2 quarters · filed 2022-03-28 | $1.14M derived: sum of 3 quarters · filed 2022-03-28 | $1.17M 10-K · filed 2022-03-28 | $1.28M 10-K · filed 2021-03-29 | ||||
| 2020-09-30 | $415.41K 10-Q · filed 2021-11-10 | $441.41K 10-Q · filed 2020-11-05 | $727.73K derived: sum of 2 quarters · filed 2021-11-10 | $757.62K 10-Q · filed 2021-11-10 | $831.66K 10-Q · filed 2020-11-05 | $921.98K derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | $312.32K 10-Q · filed 2021-08-13 | $390.26K 10-Q · filed 2021-08-13 | $506.57K derived: sum of 3 quarters · filed 2021-08-13 | $615.05K derived: sum of 4 quarters · filed 2021-08-13 | |||||
| 2020-03-31 | $77.93K 10-Q · filed 2021-05-17 | $194.25K derived: sum of 2 quarters · filed 2021-05-17 | $302.73K derived: sum of 3 quarters · filed 2021-05-17 | $380.85K derived: sum of 4 quarters · filed 2021-05-17 | |||||
| 2019-12-31 | $116.31K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-17 | $224.79K derived: sum of 2 quarters · filed 2021-05-17 | $302.91K derived: sum of 3 quarters · filed 2021-05-17 | $431.01K 10-K/A · filed 2021-05-17 | |||||
| 2019-09-30 | $108.48K 10-Q · filed 2020-11-05 | $186.60K derived: sum of 2 quarters · filed 2020-11-05 | $314.70K 10-Q · filed 2020-11-05 | $387.52K derived: sum of 4 quarters · filed 2020-11-05 | |||||
| 2019-06-30 | $78.12K 10-Q · filed 2020-08-14 | $206.22K 10-Q · filed 2020-08-14 | $279.04K derived: sum of 3 quarters · filed 2020-08-14 | $315.06K derived: sum of 4 quarters · filed 2020-08-14 | |||||
| 2019-03-31 | $128.10K 10-Q · filed 2020-05-12 | $200.92K derived: sum of 2 quarters · filed 2020-05-12 | $236.94K derived: sum of 3 quarters · filed 2020-05-12 | $255.46K derived: sum of 4 quarters · filed 2020-05-12 | |||||
| 2018-12-31 | $72.82K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | $108.84K derived: sum of 2 quarters · filed 2020-03-20 | $127.36K derived: sum of 3 quarters · filed 2020-03-20 | $203.56K 10-K · filed 2020-03-20 | |||||
| 2018-09-30 | $36.02K 10-Q · filed 2019-11-13 | $54.54K derived: sum of 2 quarters · filed 2019-11-13 | $130.74K 10-Q · filed 2019-11-13 | $186.47K derived: sum of 4 quarters · filed 2019-11-13 | |||||
| 2018-06-30 | $18.52K 10-Q · filed 2019-08-13 | $94.72K 10-Q · filed 2019-08-13 | $150.45K derived: sum of 3 quarters · filed 2019-08-13 | $187.34K derived: sum of 4 quarters · filed 2019-08-13 | |||||
| 2018-03-31 | $76.20K 10-Q · filed 2019-05-14 | $131.93K derived: sum of 2 quarters · filed 2019-05-14 | $168.82K derived: sum of 3 quarters · filed 2019-05-14 | ||||||
| 2017-12-31 | $55.73K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-04 | $92.62K derived: sum of 2 quarters · filed 2019-04-04 | $185.29K 10-K · filed 2019-04-04 | ||||||
| 2017-09-30 | $36.89K 10-Q · filed 2018-11-14 | $129.57K 10-Q · filed 2018-11-14 | |||||||
| 2013-12-31 | $52.02K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |